Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.060
-0.090 (-2.86%)
Feb 20, 2026, 4:00 PM EST - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 53.40M | 65.49M | 47.64M | 38.35M | 62.90M | | | | | |
Biotechnology (Startups) Growth | -18.47% | 37.48% | 24.22% | -39.03% | 15.00% | | | | | |
| 53.40M | 65.49M | 47.64M | 38.35M | 62.90M | | | | | |
| -18.47% | 37.48% | 24.22% | -39.03% | 15.00% | | | | | |
Source: S&P Global Market Intelligence.
